Order Article Reprints

Dorman K, Boeck S, Snijder RJ, Siveke JT, Schenk M, Mayerle J, Caca K, Freiberg-Richter J, Fischer von Weikersthal L, Kullmann F, et al. Integrated Analysis of the RASH Study with the Use of the “Burden of Therapy” (BOTh^®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current Oncology. 2023; 30(6):5828-5834. https://doi.org/10.3390/curroncol30060436

Dorman, Klara, Stefan Boeck, Robert J. Snijder, Jens T. Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, and et al. 2023. "Integrated Analysis of the RASH Study with the Use of the “Burden of Therapy” (BOTh^®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer" Current Oncology 30, no. 6: 5828-5834. https://doi.org/10.3390/curroncol30060436

Dorman, K., Boeck, S., Snijder, R. J., Siveke, J. T., Schenk, M., Mayerle, J., Caca, K., Freiberg-Richter, J., Fischer von Weikersthal, L., Kullmann, F., Reinacher-Schick, A., Fuchs, M., Kanzler, S., Kunzmann, V., Ettrich, T. J., Zhang, D., Held, S., Abdul-Ahad, A., von Bergwelt-Baildon, M., ... Haas, M. (2023). Integrated Analysis of the RASH Study with the Use of the “Burden of Therapy” (BOTh^®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current Oncology, 30(6), 5828-5834. https://doi.org/10.3390/curroncol30060436